According to filings with the U.S. Securities and Exchange Commission, Rythm Health is raising up to $31,078,122.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Rythm Health
Rythm Health is a health and wellness company that provides a subscription-based monthly at-home blood test designed for ongoing health monitoring and trend tracking over time. Through its service, individuals receive blood collection kits, follow simple, needle-free instructions to collect their own samples at home, and have those samples analyzed in accredited laboratories, with results typically delivered within a few days. The companys offering is centered on tracking key biomarkers and overall wellness via an online dashboard that visualizes trends, supports optimizing health, and informs lifestyle or supplement decisions, complemented by optional coaching and concierge-style support. Rythm Health positions its test as one of the easiest and most comfortable blood draws, emphasizing a painless, adhesive-based collection device and clear step-by-step instructions to make regular blood testing accessible to a broad consumer audience from home in under ten minutes. Headquartered in San Francisco, California, Rythm Health operates its own health monitoring platform and customer support infrastructure, reinforcing its role as a specialized provider of convenient, recurring at-home blood testing and personalized health insights.

To learn more, visit https://rythmhealth.com/
LinkedIn: https://www.linkedin.com/company/rythmlab/

Contact:
Robert Wade, Chief Executive Officer

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.